Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
7.39M
-
Shares change
-
-305K
-
Total reported value, excl. options
-
$41.9M
-
Value change
-
-$3.04M
-
Number of buys
-
26
-
Number of sells
-
-15
-
Price
-
$5.67
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q3 2018
53 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q3 2018.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.39M shares
of 72.1M outstanding shares and own 10.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.49M shares), FMR LLC (1.02M shares), Redmile Group, LLC (730K shares), COWEN INC. (708K shares), Tekla Capital Management LLC (536K shares), Vanguard Group Inc (447K shares), OppenheimerFunds, Inc. (425K shares), DEUTSCHE BANK AG\ (248K shares), BAKER BROS. ADVISORS LP (222K shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (211K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.